flu

Positive Vaccine Data Bolster Novavax

The market value of US vaccine maker Novavax is gaining momentum again on the back of promising data the company recently provided on its combined Covid and flu vaccine data.

News

CureVac Presents Positive Data from mRNA Trials

German biotech CureVac has released preliminary data from its ongoing cooperation with UK drugmaker GSK on a new class of “transformative medicines” based on messenger mRNA.

News

FDA Approves Genentech Flu Drug

News

Heavy Flu Season Helps Reckitt Beat Profit Forecasts

Top-Feature

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Global Impact Coalition (GIC)

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

flu

Positive Vaccine Data Bolster Novavax

CureVac Presents Positive Data from mRNA Trials

FDA Approves Genentech Flu Drug

Heavy Flu Season Helps Reckitt Beat Profit Forecasts

Top-Feature

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Siemens Joins the Global Impact Coalition

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Upcoming Virtual Events

Predictive Simulation in Pharma Production

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Expert Insights

ADCs for Precision Cancer Therapy

Newsletter & e-edition